Search results

From Self-sufficiency
Jump to: navigation, search
  • ====Other diseases==== ...seases (e.g. [[basal cell carcinoma]]); and treatment of inflammatory skin diseases (e.g. [[acne]]) by [[TopoTarget]]. The current names for these therapeutic
    25 KB (3,328 words) - 16:47, 27 September 2010
  • ...131919 Pharmacology, Pathology, and Historic Evidence. Clinical Infectious Diseases, 2009; DOI: 10.1086/606060</ref> Aspirin's profitability led to fierce comp ...rin's efficacy as an anti-clotting agent that reduces the risk of clotting diseases.<ref>Jeffreys, ''Aspirin'', pp. 226–231</ref> Aspirin sales revived consi
    78 KB (10,918 words) - 16:52, 27 September 2010
  • ...ystem]]. To increase the amount of dopamine in the brains of patients with diseases such as [[Parkinson's disease]] and dopa-responsive [[dystonia]], [[L-DOPA] ...phylogeny of the primate brain, with special reference to humans and their diseases. ''Brain Research Reviews'', 15, 267-294.</ref> support a dopaminergic expa
    48 KB (6,470 words) - 16:48, 27 September 2010
  • ...R. Liss, New York,.</ref> IL-1 must be especially useful in combating some diseases; however, [[endotoxin]] bacteria have gained an advantage by forcing the [[ ...Alan R. Liss, New York,.</ref> which must be especially useful for those diseases which gain an advantage by forcing the [[hypothalamus]] to secrete too much
    41 KB (5,644 words) - 16:50, 27 September 2010
  • ...w medical theories by Thomas Beddoes, that [[tuberculosis]] and other lung diseases could be treated by inhalation of "Factitious Airs"<ref name="Drug discover ...s Beddoes]] in 1798 established the ''"Pneumatic Institution for Relieving Diseases by Medical Airs"'' in [[Clifton, Bristol|Clifton (Bristol)]]. In the baseme
    61 KB (8,728 words) - 16:50, 27 September 2010
  • ...añon-Espaillat R, Mandel S |title=Diagnostic algorithms for neuromuscular diseases |journal=Clin Podiatr Med Surg |volume=16 |issue=1 |pages=67–79 |year=199
    78 KB (10,295 words) - 16:51, 27 September 2010
  • ...imp.html|title=EDTA Chelation Therapy for Atherosclerosis And Degenerative Diseases: Implausibility and Paradoxical Oxidant Effects|last=Green|first=Saul|coaut
    21 KB (2,946 words) - 15:10, 6 July 2010
  • ...utically registered as a hepatoprotector) in relation to neurodegenerative diseases (including [[Alzheimer’s disease]]) in both Russia [http://www.asx.com.au ...tly commenced being used in Russian hospitals for the treatment of [[liver diseases]] and related conditions.
    9 KB (1,206 words) - 10:11, 20 September 2010
  • ...leted uranium ammunition was used are at greater risk of suffering genetic diseases such as [[congenital malformations]], commonly called "birth defects," pass ...[[Kosovska Mitrovica]] say the number of patients suffering from malignant diseases has increased by 200% since 1998.<ref>{{cite news|url=http://news.bbc.co.uk
    80 KB (11,721 words) - 10:13, 20 September 2010
  • ..., [[cervicitis]], [[ovarian cysts]], infection from [[sexually-transmitted diseases]], simple [[urethral]] irritation (such as from a bubble bath or sexual int
    11 KB (1,551 words) - 22:06, 21 September 2010
  • ...amethoxazole"], ''ChemDB'', [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[National Institutes of Health]] (NIH)
    7 KB (978 words) - 13:12, 20 September 2010
  • ...is a secretolytic agent used in the treatment of [[respiratory|respiratory diseases]] associated with viscid or excessive [[mucus]]. It is the active ingredien Ambroxol is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport. It p
    5 KB (749 words) - 13:12, 20 September 2010
  • ...ued until about 1990, with many important scientific papers on respiratory diseases amongst miners having been published. In 1985, an important association bet ...athology Branch at IOM, and to continue his research into asbestos-related diseases. An extensive programme of research on the [[toxicology]] of [[fibres]] ha
    24 KB (3,511 words) - 21:32, 20 September 2010
  • ..."Andrews">James, William; Berger, Timothy; Elston, Dirk (2005). ''Andrews' Diseases of the Skin: Clinical Dermatology''. (10th ed.). Saunders. ISBN 0721629210. ...ental Engineering, 5th edition |chapter= Noninfectious and noncommunicable diseases and conditions associated with the environment, including air, water, and f
    90 KB (13,109 words) - 21:36, 20 September 2010
  • ...imp.html|title=EDTA Chelation Therapy for Atherosclerosis And Degenerative Diseases: Implausibility and Paradoxical Oxidant Effects|last=Green|first=Saul|coaut
    21 KB (3,011 words) - 16:51, 27 September 2010
  • ...s, through problems and mutations in globin [[gene regulation]]. All these diseases produce [[anemia]].<ref>{{cite web | url=http://web2.airmail.net/uthman/hem ...own hemoglobin variants such as [[sickle-cell anemia]] are responsible for diseases, and are considered [[hemoglobinopathies]]. Other variants cause no detecta
    67 KB (9,844 words) - 20:17, 21 September 2010
  • ...lso|Cutaneous conditions|Category:Cutaneous conditions|ICD-10 Chapter XII: Diseases of the skin and subcutaneous tissue}} ...l |author=Jackson R |title=Historical outline of attempts to classify skin diseases |journal=Can Med Assoc J |volume=116 |issue=10 |pages=1165–8 |year=1977 |
    177 KB (19,269 words) - 21:05, 21 September 2010
  • ...ction of diseases and other conditions found in the [[dog]]. Some of these diseases are unique to dogs or closely related species, while others are found in ot ==Infectious diseases==
    99 KB (14,444 words) - 21:22, 3 October 2011
  • ...been suggested to enhance healing of fractures that occur in patients with diseases such as [[diabetes]], vascular insufficiency, and [[osteoporosis]], and tho
    10 KB (1,460 words) - 22:06, 21 September 2010
  • ...ations seem manifold.<ref>Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations. Int J Dermatol. 2003;42:491-5. "PMID 1278688
    30 KB (4,025 words) - 22:06, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)